Smith & Nephew stock slumps after China-tied profit warning

Dow Jones10-31

MW Smith & Nephew stock slumps after China-tied profit warning

Shares of medical equipment maker Smith & Nephew (UK:SN) tumbled 10% in early trade as the company slashed its earnings guidance. Citing worse-than-expected headwinds in China, it now sees underlying revenue growth for the year around 4.5%, versus 5% to 6% previously. That will translate into margins - it's now seeing "up to 50 basis points" of growth versus last year's 17.5%, versus previous guidance of at least 18%. For 2025, it's expecting to lift its margin to between 19% and 20%.

-Steve Goldstein

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

October 31, 2024 04:13 ET (08:13 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment